CUSIP 126638105COMCVRXQ4 2025
19 filings · latest Jan 12, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Johnson & Johnson | 4.02M | $28.58M |
| 2 | Nea Management Company, LLC | 2.03M | $14.39M |
| 3 | Vanguard Group Inc | 1.12M | $7.96M |
| 4 | Blackrock, Inc. | 1.06M | $7.53M |
| 5 | Gsk PLC | 1.01M | $7.15M |
| 6 | Balyasny Asset Management L.P. | 814.9K | $5.79M |
| 7 | Silvercrest Asset Management Group LLC | 634.6K | $4.51M |
| 8 | Parkman Healthcare Partners LLC | 413.0K | $2.93M |
| 9 |
| 4 | Feb 6, 2025 | Vensana Capital I Gp, LLC | 13G/A | 11.0% | 1.76M | SEC |
| 5 | Nov 7, 2024 | New Enterprise Associates 10 L P | 13D/A | 9.3% | 2.25M | SEC |
| 6 | Nov 1, 2024 | Johnson & Johnson | 13G/A | 17.0% | 4.10M | SEC |
| 7 | Feb 6, 2024 | Vensana Capital I Gp, LLC | 13G/A | 8.2% | 1.71M | SEC |
| 8 | Feb 2, 2024 | Johnson & Johnson | 13G/A | 19.2% | 4.11M | SEC |
| 9 | Jan 19, 2024 | Cooperatieve Gilde Healthcare IV U.A. | 13D/A | 6.6% | 1.37M | SEC |
| 10 | Dec 29, 2023 | Cooperatieve Gilde Healthcare IV U.A. | 13D/A | 7.7% | 1.60M | SEC |
See the full Schedule 13D/13G history for Cvrx Inc.
Unlock full history| Geode Capital Management, LLC |
| 403.9K |
| $2.87M |
| 10 | Morgan Stanley | 380.6K | $2.70M |